Introducing SmartChem’s New Patent Type Filter

Timing is crucial in the pharmaceutical industry. Securing a first-to-file status or entering the market early with a generic can allow you to capture a significant portion of the revenue. However, missing that patent expiration window by just a few weeks can leave you scrambling for minimal returns.

If your team is still wading through complex patent data to figure out when an Active Pharmaceutical Ingredient (API) will go off patent, we have some exciting news.

SmartChem has just launched a significant upgrade: the Patent Type Filter.

Why This Upgrade Transforms Your Generic Pipeline

Not all patents carry the same significance. For instance, a drug may have a formulation patent that expires in 2032, while the core product patent for the API could expire in 2028. With our new filter, you can quickly identify:

Product Patents: Determine precisely when the core API goes off patent to assess early market-entry opportunities.

Pharmaceutical Composition Patents: Analyze formulation or composition patents separately to craft smarter licensing or partnership agreements.

By differentiating these patents at a glance, commercial and R&D teams can accurately pinpoint the timeline for generic market entry without the usual data noise.

Expanded Global Coverage

To ensure that your global out-licensing and in-licensing strategies are not blindsided by regional extensions, we have also expanded our global dataset. You can now access precise, up-to-date expiration data across 11 critical markets: the US, Canada, the UK, Japan, France, Germany, Slovakia, Sweden, Switzerland, Italy, and Ireland.

Accelerate Your Business Development Strategy Today

Don’t let outdated data hinder your pipeline expansion. Explore SmartChem today to try out the new Patent Type Filter and discover how quickly you can identify your next potential blockbuster generic asset.